News
TransCode Therapeutics, Inc. (Nasdaq: RNAZ), a clinical-stage oncology company developing RNA-targeted therapeutics for the treatment of cancer, today announced the appointment of Phillip D. Zamore, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback